# LAKEFRONT BIOTHERAPEUTICS NV (LKFT)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/LKFT/

- Reporting holders: 4
- Reported value: $119.7K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [GAMMA Investing LLC](https://holderbook.com/funds/2010235-gamma-investing-llc/) | $77.9K | 2,628 | 0.0% | 12 |
| [CACTI ASSET MANAGEMENT LLC](https://holderbook.com/funds/1452208-cacti-asset-management-llc/) | $29.5K | 1,000 | 0.0% | 1 |
| [Farther Finance Advisors, LLC](https://holderbook.com/funds/1992825-farther-finance-advisors-llc/) | $11.9K | 402 | 0.0% | 5 |
| [Retirement Wealth Solutions LLC](https://holderbook.com/funds/2044741-retirement-wealth-solutions-llc/) | $327 | 11 | 0.0% | 3 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 4 | $119.7K |
| Q2 2026 | 78 | $979.3M |
| Q1 2026 | 89 | $997.1M |
| Q4 2025 | 92 | $1.0B |
| Q3 2025 | 94 | $1.1B |
| Q2 2025 | 91 | $935.1M |
| Q1 2025 | 85 | $798.3M |
| Q4 2024 | 86 | $887.5M |
| Q3 2024 | 81 | $410.2M |
| Q2 2024 | 83 | $496.0M |
| Q1 2024 | 83 | $665.8M |
| Q4 2023 | 89 | $826.7M |